1. Home
  2. AMPL vs PCRX Comparison

AMPL vs PCRX Comparison

Compare AMPL & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplitude Inc.

AMPL

Amplitude Inc.

HOLD

Current Price

$13.28

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.00

Market Cap

999.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPL
PCRX
Founded
2012
2006
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
999.0M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
AMPL
PCRX
Price
$13.28
$23.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
4
Target Price
$13.42
$30.25
AVG Volume (30 Days)
2.2M
661.2K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
11.84
107.44
EPS
N/A
0.19
Revenue
$343,214,000.00
$541,533,000.00
Revenue This Year
$17.43
$6.78
Revenue Next Year
$14.16
$8.54
P/E Ratio
N/A
$122.00
Revenue Growth
14.68
26.04
52 Week Low
$5.51
$18.80
52 Week High
$13.33
$27.66

Technical Indicators

Market Signals
Indicator
AMPL
PCRX
Relative Strength Index (RSI) 74.69 34.62
Support Level $6.05 $22.03
Resistance Level N/A $24.34
Average True Range (ATR) 0.64 1.05
MACD 0.35 -0.44
Stochastic Oscillator 88.23 4.31

Price Performance

Historical Comparison
AMPL
PCRX

About AMPL Amplitude Inc.

Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue through selling subscriptions to the platform. The company derives a majority of its revenue from the United States, and also has its presence in Internationally.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: